Design, synthesis, and evaluation of benzothiadiazepine hydroxamates as selective tumor necrosis factor-alpha converting enzyme inhibitors.
Cherney RJ, Duan JJ, Voss ME, Chen L, Wang L, Meyer DT, Wasserman ZR, Hardman KD, Liu RQ, Covington MB, Qian M, Mandlekar S, Christ DD, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP.
Cherney RJ, et al. Among authors: covington mb.
J Med Chem. 2003 May 8;46(10):1811-23. doi: 10.1021/jm020475w.
J Med Chem. 2003.
PMID: 12723945